Voxel
Market Cap
zł451.6m
Last Updated
2021/01/21 18:09 UTC
Data Sources
Company Financials
Executive Summary
Voxel S.A. operates a network of diagnostic imaging laboratories. More Details
Rewards
Risk Analysis
Snowflake Analysis
Good value with imperfect balance sheet.
Share Price & News
How has Voxel's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: VOX is less volatile than 75% of Polish stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: VOX's weekly volatility (5%) has been stable over the past year.
Market Performance
7 Day Return
-0.7%
VOX
0.9%
PL Healthcare
-2.7%
PL Market
1 Year Return
34.7%
VOX
58.5%
PL Healthcare
0.3%
PL Market
Return vs Industry: VOX underperformed the Polish Healthcare industry which returned 58.2% over the past year.
Return vs Market: VOX exceeded the Polish Market which returned 2% over the past year.
Shareholder returns
| VOX | Industry | Market | |
|---|---|---|---|
| 7 Day | -0.7% | 0.9% | -2.7% |
| 30 Day | 5.6% | 5.4% | 3.7% |
| 90 Day | 1.2% | 14.3% | 15.9% |
| 1 Year | 37.7%34.7% | 60.3%58.5% | 1.3%0.3% |
| 3 Year | 124.6%103.3% | 96.6%88.5% | -13.8%-19.0% |
| 5 Year | 132.3%97.3% | 109.9%93.7% | 22.4%8.5% |
Long-Term Price Volatility Vs. Market
How volatile is Voxel's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall St
Should You Be Impressed By Voxel's (WSE:VOX) Returns on Capital?1 month ago | Simply Wall St
What Is The Ownership Structure Like For Voxel S.A. (WSE:VOX)?2 months ago | Simply Wall St
We're Not Counting On Voxel (WSE:VOX) To Sustain Its Statutory ProfitabilityValuation
Is Voxel undervalued compared to its fair value and its price relative to the market?
22.0%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: VOX (PLN43.1) is trading below our estimate of fair value (PLN55.26)
Significantly Below Fair Value: VOX is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: VOX is good value based on its PE Ratio (22x) compared to the PL Healthcare industry average (42.2x).
PE vs Market: VOX is poor value based on its PE Ratio (22x) compared to the Polish market (13.8x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate VOX's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: VOX is good value based on its PB Ratio (2.8x) compared to the PL Healthcare industry average (3.4x).
Next Steps
Future Growth
How is Voxel forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
17.7%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Voxel has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Next Steps
- Examine whether Voxel is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- Voxel competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
Past Performance
How has Voxel performed over the past 5 years?
15.9%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: VOX has a large one-off gain of PLN9.1M impacting its September 30 2020 financial results.
Growing Profit Margin: VOX's current net profit margins (8%) are lower than last year (12.1%).
Past Earnings Growth Analysis
Earnings Trend: VOX's earnings have grown by 15.9% per year over the past 5 years.
Accelerating Growth: VOX's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: VOX had negative earnings growth (-18.7%) over the past year, making it difficult to compare to the Healthcare industry average (-0.3%).
Return on Equity
High ROE: VOX's Return on Equity (12.7%) is considered low.
Next Steps
Financial Health
How is Voxel's financial position?
Financial Position Analysis
Short Term Liabilities: VOX's short term assets (PLN102.1M) do not cover its short term liabilities (PLN149.6M).
Long Term Liabilities: VOX's short term assets (PLN102.1M) do not cover its long term liabilities (PLN104.1M).
Debt to Equity History and Analysis
Debt Level: VOX's debt to equity ratio (64.8%) is considered high.
Reducing Debt: VOX's debt to equity ratio has increased from 40.3% to 64.8% over the past 5 years.
Debt Coverage: VOX's debt is well covered by operating cash flow (50.1%).
Interest Coverage: VOX's interest payments on its debt are well covered by EBIT (5x coverage).
Balance Sheet
Next Steps
Dividend
What is Voxel current dividend yield, its reliability and sustainability?
2.11%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: VOX's dividend (2.11%) is higher than the bottom 25% of dividend payers in the Polish market (1.55%).
High Dividend: VOX's dividend (2.11%) is low compared to the top 25% of dividend payers in the Polish market (5.03%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, VOX has been paying a dividend for less than 10 years.
Growing Dividend: VOX's dividend payments have increased, but the company has only paid a dividend for 5 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (46.5%), VOX's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
zł721k
CEO Compensation
CEO
Jaroslaw Furdal
no data
Tenure
zł721,000
Compensation
Mr. Jaroslaw Furdal has been Chairman of the Management Board at Voxel S.A.
CEO Compensation Analysis
Compensation vs Market: Jaroslaw's total compensation ($USD193.19K) is about average for companies of similar size in the Polish market ($USD153.23K).
Compensation vs Earnings: Jaroslaw's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Voxel S.A.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Voxel S.A.
- Ticker: VOX
- Exchange: WSE
- Founded: 2005
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: zł451.612m
- Shares outstanding: 10.50m
- Website: https://www.voxel.pl
Location
- Voxel S.A.
- ul. Wielicka 265
- Kraków
- 30-663
- Poland
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| VOX | WSE (Warsaw Stock Exchange) | Yes | Common Bearer Shares | PL | PLN | Oct 2011 |
| 0QDB | LSE (London Stock Exchange) | Yes | Common Bearer Shares | GB | PLN | Oct 2011 |
Biography
Voxel S.A. operates a network of diagnostic imaging laboratories. Its diagnostic imaging services include magnetic resonance imaging scans, computed tomography scans, positron emission tomography, and sing...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/21 18:09 |
| End of Day Share Price | 2021/01/21 00:00 |
| Earnings | 2020/09/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.